Telitacicept versus mycophenolate mofetil in IgA nephropathy: a real-world comparative study of efficacy, renal outcomes and safety.

Clin Kidney J · 2025 · PMC12415519 · PMID 40927377

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline significanceP = .051so close (0.05 < p ≤ 0.1)

The crude model had borderline significance (HR 2.26, P = .051), while propensity score–adjusted (HR 9.92, P = .002) and IPTW models (HR 13.98, P < .001) showed strong effects.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.